Status dystonicus (SD) is a life threatening disorder that develops in patients with both primary and secondary dystonia, characterized by acute worsening of symptoms with generalized and severe muscle contractions. To date, no information is available on the best way to treat this disorder. We review the previously described cases of SD and two new cases are reported, one of which occurring in a child with static encephalopathy, and the other one in a patient with pantothenate kinase-associated neurodegeneration. Both patients were admitted to an intensive care unit and treated with midazolam and propofol. This approach proved to be useful in the former while the progressive nature of the dystonia of the second patient required the combination of intrathecal baclofen infusion and bilateral pallidal deep brain stimulation. We believe that a rapid and aggressive approach is justified to avoid the great morbidity and mortality which characterize SD. Our experience, combined with the data available in the literature, might permit to establish the best strategies in managing this rare and severe condition.

Mariotti, P., Fasano, A., Contarino, M. F., Della Marca, G., Piastra, M., Genovese, O., Pulitano', S. M., Chiaretti, A., Bentivoglio, A. R., Management of status dystonicus: our experience and review of the literature, <<MOVEMENT DISORDERS>>, 2007; 22 (7): 963-968. [doi:10.1002/mds.21471] [http://hdl.handle.net/10807/31668]

Management of status dystonicus: our experience and review of the literature

Mariotti, Paolo;Fasano, Alfonso;Contarino, Maria Fiorella;Della Marca, Giacomo;Piastra, Marco;Genovese, Orazio;Pulitano', Silvia Maria;Chiaretti, Antonio;Bentivoglio, Anna Rita
2007

Abstract

Status dystonicus (SD) is a life threatening disorder that develops in patients with both primary and secondary dystonia, characterized by acute worsening of symptoms with generalized and severe muscle contractions. To date, no information is available on the best way to treat this disorder. We review the previously described cases of SD and two new cases are reported, one of which occurring in a child with static encephalopathy, and the other one in a patient with pantothenate kinase-associated neurodegeneration. Both patients were admitted to an intensive care unit and treated with midazolam and propofol. This approach proved to be useful in the former while the progressive nature of the dystonia of the second patient required the combination of intrathecal baclofen infusion and bilateral pallidal deep brain stimulation. We believe that a rapid and aggressive approach is justified to avoid the great morbidity and mortality which characterize SD. Our experience, combined with the data available in the literature, might permit to establish the best strategies in managing this rare and severe condition.
2007
Inglese
Mariotti, P., Fasano, A., Contarino, M. F., Della Marca, G., Piastra, M., Genovese, O., Pulitano', S. M., Chiaretti, A., Bentivoglio, A. R., Management of status dystonicus: our experience and review of the literature, <<MOVEMENT DISORDERS>>, 2007; 22 (7): 963-968. [doi:10.1002/mds.21471] [http://hdl.handle.net/10807/31668]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/31668
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 98
  • ???jsp.display-item.citation.isi??? ND
social impact